Application of pharmaceutical composition in the process for preparing medicine to counteract aspirin resisting medicine
A kind of technology of aspirin and composition
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Publication Date
- 2005-07-06
Abstract
Description
technical field
[0001] The invention belongs to the field of medicine, and in particular relates to the application of a pharmaceutical composition in the preparation of anti-aspirin resistance drugs. Background technique
[0002] Aspirin (Aspirin), also aspirin or acetylsalicylic acid, has been used clinically for more than 80 years and is an ancient antipyretic and analgesic. In recent years, with the in-depth research on prostaglandins, new understandings have been gained on aspirin: in addition to being traditionally used for antipyretic, analgesic and anti-inflammatory, it is also used for anti-platelet aggregation in clinical practice. Clinical trials have shown that aspirin is an effective antiplatelet drug for the primary prevention of high-risk patients with cardiovascular and cerebrovascular diseases, and is also effective for the secondary prevention of myocardial infarction and ischemic vascular events.
[0003] However, at presen...
Examples
Embodiment 1
[0103] Take the Radix Paeoniae Alba in the amount of raw materials, add water and decoct 2-4 times, combine the decoction, filter, and concentrate the filtrate under reduced pressure to a relative density of 1.20-1.50 (50°C), dry, powder into fine powder, and then add the Ginseng stem and leaf saponins and 20-80 weight units of stevioside fine powder (sweetener) and 1-10 weight units of starch are granulated with 60%-80% ethanol, dried, and packed into capsules (each About 0.25g of medicine is filled in the capsule), and the product is obtained.
Embodiment 2
[0105] Take the Radix Paeoniae Alba in the amount of raw materials, add water and decoct 2-4 times, combine the decoction, filter, concentrate the filtrate under reduced pressure to a relative density of 1.20-1.50 (50°C), dry, powder into fine powder, and then add it to the amount of raw materials in turn Ginseng stem and leaf saponins and 20-60 weight units of stevioside fine powder (sweetener) and 1-10 weight units of starch are granulated with 60%-80% ethanol, dried, and magnesium stearate is added 1-5 weight units, mixed evenly, pressed into tablets (core weight 0.39 / tablet), and then coating the core with sugar (15-20kg of white granulated sugar for each kg of tablet core, 14-20kg of talcum powder, polished) , the product is obtained.